Curcumin is the primary polyphenol in turmeric's curcuminoid class. It has a wide range of
therapeutic applications, such as anti-inflammatory, antioxidant, antidiabetic …

Rapidly developing molecular biology techniques have been employed to identify cancer
driver genes in specimens from patients with non-small cell lung cancer (NSCLC). Inhibitors …

Introduction Dabrafenib plus trametinib was found to have robust antitumor activity in
patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC). We report updated …

The most prevalent and deadly primary malignant glioma in adults is glioblastoma (GBM),
which has a median survival time of about 15 months. Despite the standard of care for …

The essence of precision medicine is to achieve the goal of “individualized treatment”
through genotyping of patients and targeted therapy. At present, the pathogenic genes of …

The treatment of metastatic non-small cell lung cancer (NSCLC) has undergone a paradigm
shift over the last decade. Better molecular characterization of the disease has led to the …

Lung cancer (LC) represents the second most diagnosed tumor and the malignancy with the
highest mortality rate. In recent years, tremendous progress has been made in the treatment …

Non‑small cell lung cancer (NSCLC) is a malignant tumor with a high morbidity and mortality
rate that is a threat to human health. With the development of molecular targeted research …

The anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase known for its oncogenic
potential that is involved in the development of the peripheral and central nervous system …

Since the discovery of targeted therapy with epidermal growth factor receptor (EGFR),
anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) have been introduced as …